Susquehanna International Group’s Nuvation Bio NUVB Stock Holding History

Susquehanna International Group’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$983K	Sell	229,100 -75,000	-25%	-$418K	﹤0.01%	7932
2025 Q4	$2.72M	Buy	304,100 +55,700	+22%	+$345K	﹤0.01%	5051
2025 Q3	$919K	Buy	248,400 +134,600	+118%	+$367K	﹤0.01%	7552
2025 Q2	$222K	Buy	+113,800	New	+$237K	﹤0.01%	10998
2022 Q4	–	Sell	-10,100	Closed	-$23K	–	13284
2022 Q3	$23K	Buy	+10,100	New	+$28.8K	﹤0.01%	12554
2022 Q1	–	Sell	-14,600	Closed	-$124K	–	13674
2021 Q4	$124K	Sell	14,600 -7,000	-32%	-$64.3K	﹤0.01%	11982
2021 Q3	$215K	Sell	21,600 -62,700	-74%	-$568K	﹤0.01%	11334
2021 Q2	$785K	Buy	+84,300	New	+$961K	﹤0.01%	8430

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group's NUVB Position: Q1 2026 in Review

Susquehanna International Group increased its Nuvation Bio (NUVB) stake by 805% in Q1 2026, buying an estimated $712K and bringing the position to 143,613 shares worth $616K. The position accounts for ﹤0.01% of the portfolio, ranked #9119.

Susquehanna International Group first reported a position in NUVB in Q1 2021 and has held it in 19 quarters since. The position peaked at $3.03M in Q3 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

Susquehanna International Group held 143,613 shares of Nuvation Bio worth $616K as of Q1 2026.
Susquehanna International Group bought 127,751 Nuvation Bio shares in Q1 2026, an estimated $712K.
Nuvation Bio made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9119 holding.
Susquehanna International Group first reported a position in Nuvation Bio in Q1 2021 and has held it in 19 quarters since.
Susquehanna International Group's Nuvation Bio position peaked at $3.03M in Q3 2025.
231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.